Neurocysticercosis: Current knowledge and advances

被引:14
|
作者
Shandera, Wayne X. [1 ]
Kass, Joseph S. [1 ]
机构
[1] Sect Gen Med, Dept Med, Houston, TX 77030 USA
关键词
D O I
10.1007/s11910-006-0046-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neurocysticercosis is the most common cause of acquired seizures worldwide. Most cases of this larval stage infection of the pork tapeworm Taenia solium occur in the developing world, although increasing numbers of cases are being recognized in the United States, particularly among Hispanic immigrants. The ability of the pathogen to persist for years within the host is the subject of immunologic and biochemical investigation. The major presenting symptom is seizures, although symptoms of obstructive hydrocephalus occur if cysts are located near the ventricles or in the subarachnoid spaces. Diagnosis is dependent on clinical, radiologic, and serologic data. Therapy with antiparasitic agents, especially albendazole, is effective in large burden disease or disease within sensitive neuraxis sites (the ventricles, the subarachnoid spaces). When patients with radiologically enhancing disease are given cysticidal therapy, there appears to be a reduction in seizure recurrences. Surgery is indicated for disease in selected anatomic sites. Longterm prevention requires attention to pork husbandry and general sanitation, including the potential use of mass human chemotherapy and porcine vaccination.
引用
收藏
页码:453 / 459
页数:7
相关论文
共 50 条
  • [1] Neurocysticercosis: Current knowledge and advances
    Wayne X. Shandera
    Joseph S. Kass
    [J]. Current Neurology and Neuroscience Reports, 2006, 6 : 453 - 459
  • [2] NEUROCYSTICERCOSIS - DIAGNOSTIC AND THERAPEUTIC ADVANCES
    GERKEN, G
    MULLER, J
    ROTH, R
    MANNS, M
    PORALLA, T
    HUTTEROTH, TH
    ZUMBUSCHENFELDE, KHM
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1986, 111 (23) : 899 - 902
  • [3] Recent Advances in the Diagnosis of Neurocysticercosis
    Nicholas A. Gadea
    Gabriela Matamoros
    Maria Mercedes Rueda
    [J]. Current Treatment Options in Infectious Diseases, 2018, 10 (3) : 410 - 420
  • [4] Recent Advances in the Diagnosis of Neurocysticercosis
    Gadea, Nicholas A.
    Matamoros, Gabriela
    Rueda, Maria Mercedes
    [J]. CURRENT TREATMENT OPTIONS IN INFECTIOUS DISEASES, 2018, 10 (03) : 410 - 420
  • [5] NEUROCYSTICERCOSIS - ADVANCES IN PRAZIQUANTEL TREATMENT
    GROLL, E
    [J]. TROPICAL MEDICINE AND PARASITOLOGY, 1987, 38 (03): : 261 - 261
  • [6] Brucella Spondylitis: Current Knowledge and Recent Advances
    Spernovasilis, Nikolaos
    Karantanas, Apostolos
    Markaki, Ioulia
    Konsoula, Afroditi
    Ntontis, Zisis
    Koutserimpas, Christos
    Alpantaki, Kalliopi
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (02)
  • [7] ADENOCARCINOMA OF THE STOMACH - CURRENT KNOWLEDGE AND RECENT ADVANCES
    AHMANN, FR
    [J]. ARIZONA MEDICINE, 1979, 36 (04) : 279 - 280
  • [8] Current Diagnostic Criteria for Neurocysticercosis
    Guzman, Carolina
    Garcia, Hector H.
    [J]. RESEARCH AND REPORTS IN TROPICAL MEDICINE, 2021, 12 : 197 - 203
  • [9] Cysticercosis: Recent advances in diagnosis and management of neurocysticercosis
    Yancey L.S.
    Diaz-Marchan P.J.
    White A.C.
    [J]. Current Infectious Disease Reports, 2005, 7 (1) : 39 - 47
  • [10] Mediterranean Spotted Fever: Current Knowledge and Recent Advances
    Spernovasilis, Nikolaos
    Markaki, Ioulia
    Papadakis, Michail
    Mazonakis, Nikolaos
    Ierodiakonou, Despo
    [J]. TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2021, 6 (04)